PMID: 6160561Sep 1, 1980Paper

Severe conduction disturbances and ventricular arrhythmias complicating mediastinal irradiation for Hodgkin's disease: a case report

Pacing and Clinical Electrophysiology : PACE
L Mary-RabineH E Kulbertus

Abstract

A 27-year-old male had undergone mediastinal and retroperitoneal irradiation for stage IIIA Hodgkin's disease at age 19. When he was admitted to the hospital, because of lightheadedness and syncope, trifascicular bundle branch block was noted and the patient underwent a clinical electrophysiological investigation. AH and HV intervals were prolonged and ventricular fibrillation was induced during programmed right ventricular stimulation. Serial electrophysiological studies allowed us to prescribe effective antiarrhythmic drug therapy with no recurrence of symptoms during a follow-up period of 12 months.

References

Nov 29, 1979·The New England Journal of Medicine·J F DesforgesA Piro
Oct 1, 1979·The American Journal of Cardiology·M E JosephsonL N Horowitz
Dec 1, 1978·The American Journal of Cardiology·S R SpielmanM E Josephson
Nov 1, 1976·Cancer·M K AliC C Shullenberger
Feb 1, 1975·The American Journal of Cardiology·R G MartinP H Wiernik
Jan 1, 1976·The American Journal of Medicine·R A McReynoldsW C Roberts
Nov 1, 1974·Circulation·R D GreenwoodA S Nadas
Apr 1, 1971·American Heart Journal·S J PhillipsR Rugh
Mar 1, 1968·Archives of Internal Medicine·G E BurchH L Colcolough
May 27, 1961·JAMA : the Journal of the American Medical Association·A F GOGGIOW S PALMER

❮ Previous
Next ❯

Citations

Oct 1, 1993·Seminars in Roentgenology·E M Loyer, E S Delpassand
Jul 1, 1991·Pacing and Clinical Electrophysiology : PACE·M S SlamaG Motté
Sep 1, 1983·Pacing and Clinical Electrophysiology : PACE·S Bharati, M Lev

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.